|
JNJ-86974680 Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since August 2026
Pipeline
Phase 1: 1
Top Sponsors
- Janssen Research & Development, LLC1
Indications
- Prostatic Neoplasms1
- Cancer1
Sarasota, Florida1 trial
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Florida Cancer Specialists
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.